Immunodiagnostic Systems Holdings Plc

Immunodiagnostic Systems (IDH)

Company name:Immunodiagnostic Systems Holdings Plc
EPIC:IDHTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00B01YZ052
Market Segment:ASQ1Share Type:DE
WWW Address: 2P
 Price Price Change [%] Bid Offer Open High Low Volume
 210.00 0.0 [0.00] 200.00 220.00 210.00 217.00 210.00 -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 60.45 28.78 0.06 11.60 1.90 18.10 0.90 405.00 - 167.50

Immunodiagnostic Systems Key Figures

(at previous day's close)
Market Cap.60.45m
Shares In Issue28.78m
Prev. Close210.00
PE Ratio18.10 
Dividend Yield0.90%
EPS - basic11.60p
Dividend PS1.90p
Dividend Cover6.11 
Cash Flow PS19.26p
Return On Equity (ROE)5.86%
Operating Margin8.23%
PEG Factor0.05 
EPS Growth Rate329.63%
Dividends PS Growth Rate171.43%
Net Debt-11.37m
Gross Gearing22.12%
Quick Assets40.99m
Net Working Capital40.61m
Intangibles / Fixed Assets53.21%
Turnover PS137.39p
Pre-Tax Profit PS11.30p
Retained Profit PS10.93p
Cash PS95.83p
Net Cash PS57.20p
Net Tangible Asset Value PS *158.46p
Net Asset Value PS198.34p
Spread20.00 (9.09%) 

Immunodiagnostic Systems Balance Sheet


Share Price Performance

Sample Period HighLow
1 week221.00210.00
4 weeks234.00206.00
12 weeks305.00195.00
1 year405.00167.50

Share Price Chart (5 years)

Immunodiagnostic Systems Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week210.00--210.000.00213.05
4 weeks225.00-15.00-6.67206.000.00213.77
12 weeks195.0015.007.69195.000.01225.88
26 weeks240.00-30.00-12.50190.000.01231.81
1 year265.00-55.00-20.75167.500.01248.65
3 years290.00-80.00-27.59160.000.01231.35
5 years227.50-17.50-7.69112.500.01209.74

Immunodiagnostic Systems Key Management Ratios

Immunodiagnostic Systems Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio4.87 
PE Ratio18.10 
Tobin's Q Ratio 0.87 
Tobin's Q Ratio (excl. intangibles)1.04 
Dividend Yield0.90%
Market-to-Book Ratio1.06 
Price-to-Pre-Tax Profit PS18.58 
Price-to-Retained Profit PS19.21 
Price-to-Cash Flow PS10.91 
Price-to-Sales PS1.53 
Price-to-Net Tangible Asset Value PS1.33 
Price-to-Cash PS2.19 
Net Working Capital PS141.10 
Price Pct to Working Capital PS1.49%
Earnings Yield5.52%
Average PE40.58 
Years in average4 
PE to PE average44.61%

Immunodiagnostic Systems Financial Ratios

(Leverage Ratios)
Debt Ratio8.20%
Debt-to-Equity Ratio0.09 
Debt-to-Equity Ratio (excl. Intgbl)0.11 
Debt-to-Equity Market Value0.08 
Net Gearing-15.50%
Net Gearing (excl. Intangibles)-18.38%
Gross Gearing22.12%
Gross Gearing (excl. Intangibles)26.23%
Gearing Under 1 Year15.17%
Gearing Under 1 Year (excl. Intgbl)17.98%
(Liquidity Ratios)
Net Working Capital to Total Assets55.40%
Current Ratio4.65 
Quick Ratio (Acid Test)3.69 
Liquidity Ratio2.48 
Cash & Equiv/Current Assets53.32%
(Solvency Ratios)
Enterprise Value37.96m
CFO/Attributable Profit1.66 
Total Debt/Equity Market Value0.27 
Total Debt/Sales0.41 
Total Debt/Pre-Tax Profit4.98 
Total Debt16.22m
Total Debt/Net Current Assets0.40%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth40.30%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)

Immunodiagnostic Systems Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)5.23%
Return On Assets (ROA)4.81%
Net Profit Margin8.47%
Assets Turnover0.57 
Return On Equity (ROE)5.86%
Return On Investment (ROI)5.54%
Dividend Payout Ratio16.38%
Plowback Ratio83.62%
Growth from Plowback Ratio4.98%
Net Income Of Revenues7.96%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.70 
Fixed Assets Turnover1.96 
Current Assets Turnover0.80 
Net Working Capital Turnover 
Inventory Turnover4.26 
(Other Operating Ratios)
Total Assets-to-Sales1.76 
Debt Collection Period115.85Days

Immunodiagnostic Systems Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
17 Jun 2020FinalGBX1.9031/03/201931/03/202016/07/202017/07/202014/08/20201.90
19 Jun 2019FinalGBX0.7031/03/201831/03/201918/07/201919/07/201916/08/20190.70
20 Jun 2018FinalGBX1.7031/03/201731/03/201819/07/201820/07/201817/08/20181.70
21 Jun 2017FinalGBX4.0031/03/201631/03/201720/07/201721/07/201718/08/20174.00
22 Jun 2016FinalGBX1.2031/03/201531/03/201621/07/201622/07/201619/08/20161.20
23 Jun 2015FinalGBX3.0031/03/201431/03/201523/07/201524/07/201521/08/20153.00
24 Jun 2014FinalGBX8.5031/03/201331/03/201423/07/201425/07/201422/08/20148.50
17 Jun 2013FinalGBX3.0031/03/201231/03/201324/07/201326/07/201323/08/20133.00
25 Jun 2012FinalGBX2.7531/03/201131/03/201205/09/201207/09/201228/09/20122.75
27 Jun 2011FinalGBX2.5031/03/201031/03/201131/08/201102/09/201129/09/20112.50
12 Jul 2010FinalGBX2.0031/03/200931/03/201018/08/201020/08/201015/09/20102.00
22 Jun 2009FinalGBX1.6531/03/200831/03/200922/07/200924/07/200921/08/20091.65
16 Jul 2008FinalGBX1.5031/03/200731/03/200820/08/200822/08/200812/09/20081.50
16 Jul 2007FinalGBX1.2531/03/200631/03/200722/08/200724/08/200726/09/20071.25
05 Jul 2006FinalGBX1.0031/03/200531/03/200623/08/200625/08/200625/09/20061.00

Immunodiagnostic Systems Fundamentals

 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
pre tax profit1.192.97%0.942.46%0.842.19%3.258.23%m
attributable profit3.017.52%1.233.23%0.802.07%3.358.47%m
retained profit2.666.63%0.050.13%0.300.77%3.157.96%m
eps - basic (p)10.20 4.20 2.70 11.60 
eps - diluted (p)10.20 4.20 2.70 11.60 
dividends per share4.00 1.70 0.70 1.90 

Immunodiagnostic Systems Balance Sheet

 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
fixed assets fixed assets8.5112.37%7.4711.06%6.8510.39%9.8113.38%m
intangibles intangibles10.4515.20%10.9916.28%11.1816.96%11.4815.66%m
fixed investments fixed investments0.330.48%0.350.52%0.661.01%0.290.39%m
current assets - other current assets - other--%--%--%--%m
stocks stocks7.5711.02%8.3812.40%7.8211.86%10.7414.65%m
debtors debtors10.3815.10%11.8217.50%11.7017.74%13.4118.29%m
cash & securities cash & securities31.5045.82%28.5342.25%27.7142.04%27.5837.63%m
creditors - short creditors - short8.2211.96%7.2610.75%7.3211.10%11.1215.17%m
creditors - long creditors - long3.785.51%3.415.04%3.305.00%5.106.96%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves56.7382.54%56.8784.20%55.3083.90%57.0977.88%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Immunodiagnostic Systems Cash Flow Statement

31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
Operating CF8.442.525.785.54m
Pre-Financing CF4.81-1.351.350.88m
Retained CF4.27-2.76-0.67-0.06m

Immunodiagnostic Systems Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Oriel Securities LimitedMarket Maker(MMF)Broker/DealerORELORSNGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210120 01:10:48